Sun Pharmaceuticals Industries Ltd is currently trading at Rs. 790, up by Rs. 7.8 or 1% from its previous closing of Rs. 782.2 on the BSE.
Sun Pharma today announced that one of its subsidiaries has received final approval from US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Crestor® , Rosuvastatin Calcium tablets 5 mg (base), 10 mg (base), 20 mg (base) and 40 mg (base).
These Rosuvastatin Calcium tablets are therapeutic equivalents of IPR Pharmaceuticals, Inc.’s Crestor® tablets. As per IMS MAT May 2016, these tablets have annual sales of approximately US$ 6.8 billion in the US. These tablets are indicated for the treatment of adult patients with Hypertriglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) and adult patients with Homozygous Familial Hypercholesterolemia.
Sun Pharmaceuticals Industries Ltd is currently trading at Rs. 790, up by Rs. 7.8 or 1% from its previous closing of Rs. 782.2 on the BSE.
The scrip opened at Rs. 785 and has touched a high and low of Rs. 790.45 and Rs. 782 respectively. So far 1751117(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 188256.29 crore.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 965.15 on 20-Aug-2015 and a 52 week low of Rs. 706.4 on 24-Nov-2015. Last one week high and low of the scrip stood at Rs. 794.75 and Rs. 765 respectively.
The promoters holding in the company stood at 54.97 % while Institutions and Non-Institutions held 35.37 % and 9.65 % respectively.
The stock is currently trading above its 200 DMA.
These Rosuvastatin Calcium tablets are therapeutic equivalents of IPR Pharmaceuticals, Inc.’s Crestor® tablets. As per IMS MAT May 2016, these tablets have annual sales of approximately US$ 6.8 billion in the US. These tablets are indicated for the treatment of adult patients with Hypertriglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) and adult patients with Homozygous Familial Hypercholesterolemia.
Sun Pharmaceuticals Industries Ltd is currently trading at Rs. 790, up by Rs. 7.8 or 1% from its previous closing of Rs. 782.2 on the BSE.
The scrip opened at Rs. 785 and has touched a high and low of Rs. 790.45 and Rs. 782 respectively. So far 1751117(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 188256.29 crore.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 965.15 on 20-Aug-2015 and a 52 week low of Rs. 706.4 on 24-Nov-2015. Last one week high and low of the scrip stood at Rs. 794.75 and Rs. 765 respectively.
The promoters holding in the company stood at 54.97 % while Institutions and Non-Institutions held 35.37 % and 9.65 % respectively.
The stock is currently trading above its 200 DMA.
No comments:
Post a Comment